Equities Analysts Set Expectations for INSP FY2028 Earnings

Inspire Medical Systems, Inc. (NYSE:INSP) – Stock analysts at Leerink Partnrs lowered their FY2028 earnings per share (EPS) estimates for Inspire Medical Systems in a report issued on Tuesday, February 11th. Leerink Partnrs analyst M. Kratky now forecasts that the company will post earnings of $5.62 per share for the year, down from their prior estimate of $5.69. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $1.33 per share.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, February 10th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%.

Several other equities analysts have also recently commented on INSP. KeyCorp reissued an “overweight” rating and set a $234.00 target price (down previously from $236.00) on shares of Inspire Medical Systems in a research note on Friday, January 24th. Wells Fargo & Company lowered their price objective on shares of Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Truist Financial dropped their target price on Inspire Medical Systems from $250.00 to $235.00 and set a “buy” rating on the stock in a report on Tuesday. Royal Bank of Canada reaffirmed an “outperform” rating and set a $260.00 price target on shares of Inspire Medical Systems in a research note on Tuesday. Finally, Morgan Stanley dropped their price objective on Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating on the stock in a research note on Tuesday. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $228.82.

Inspire Medical Systems Stock Performance

Shares of INSP opened at $187.23 on Wednesday. Inspire Medical Systems has a one year low of $123.00 and a one year high of $257.40. The stock’s fifty day moving average is $189.20 and its 200-day moving average is $191.36. The firm has a market capitalization of $5.61 billion, a price-to-earnings ratio of 174.98 and a beta of 1.32.

Hedge Funds Weigh In On Inspire Medical Systems

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. State Street Corp raised its holdings in shares of Inspire Medical Systems by 78.0% during the third quarter. State Street Corp now owns 1,049,784 shares of the company’s stock worth $221,557,000 after acquiring an additional 459,990 shares in the last quarter. TimesSquare Capital Management LLC acquired a new position in Inspire Medical Systems in the 4th quarter worth about $80,419,000. Point72 Asset Management L.P. raised its stake in shares of Inspire Medical Systems by 954.4% during the 3rd quarter. Point72 Asset Management L.P. now owns 319,364 shares of the company’s stock worth $67,402,000 after purchasing an additional 289,075 shares in the last quarter. Marshall Wace LLP lifted its holdings in shares of Inspire Medical Systems by 1,775.3% during the 4th quarter. Marshall Wace LLP now owns 277,131 shares of the company’s stock valued at $51,375,000 after buying an additional 262,353 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Inspire Medical Systems during the 4th quarter valued at about $47,604,000. 94.91% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, CTO John Rondoni sold 583 shares of the business’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.67. Following the sale, the chief technology officer now owns 10,424 shares in the company, valued at $1,777,187.76. The trade was a 5.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 4.10% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.